Request for Covid-19 Impact Assessment of this Report
The United States SARS-CoV-2 IgG (RBD) ELISA market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global SARS-CoV-2 IgG (RBD) ELISA market, reaching US$ million by the year 2028. As for the Europe SARS-CoV-2 IgG (RBD) ELISA landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main SARS-CoV-2 IgG (RBD) ELISA players cover R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, and BD Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of SARS-CoV-2 IgG (RBD) ELISA market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
ELISA Sets
ELISA Kits
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Disease control and prevention system
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
LOEWE Biochemica
Shenzhen YHLO Biotech
LG
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2028
2.1.2 SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 SARS-CoV-2 IgG (RBD) ELISA Segment by Type
2.2.1 ELISA Sets
2.2.2 ELISA Kits
2.3 SARS-CoV-2 IgG (RBD) ELISA Market Size by Type
2.3.1 SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)
2.4 SARS-CoV-2 IgG (RBD) ELISA Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Disease control and prevention system
2.5 SARS-CoV-2 IgG (RBD) ELISA Market Size by Application
2.5.1 SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)
3 SARS-CoV-2 IgG (RBD) ELISA Market Size by Player
3.1 SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Players
3.1.1 Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2020-2022)
3.1.2 Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Players (2020-2022)
3.2 Global SARS-CoV-2 IgG (RBD) ELISA Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SARS-CoV-2 IgG (RBD) ELISA by Regions
4.1 SARS-CoV-2 IgG (RBD) ELISA Market Size by Regions (2017-2022)
4.2 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)
4.3 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)
4.4 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)
4.5 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth (2017-2022)
5 Americas
5.1 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022)
5.2 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
5.3 Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022)
6.2 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
6.3 APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe SARS-CoV-2 IgG (RBD) ELISA by Country (2017-2022)
7.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
7.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA by Region (2017-2022)
8.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022)
8.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.1 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Regions (2023-2028)
10.1.1 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Regions (2023-2028)
10.1.2 Americas SARS-CoV-2 IgG (RBD) ELISA Forecast
10.1.3 APAC SARS-CoV-2 IgG (RBD) ELISA Forecast
10.1.4 Europe SARS-CoV-2 IgG (RBD) ELISA Forecast
10.1.5 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Forecast
10.2 Americas SARS-CoV-2 IgG (RBD) ELISA Forecast by Country (2023-2028)
10.2.1 United States SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.2.2 Canada SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.2.3 Mexico SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.2.4 Brazil SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.3 APAC SARS-CoV-2 IgG (RBD) ELISA Forecast by Region (2023-2028)
10.3.1 China SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.3.2 Japan SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.3.3 Korea SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.3.4 Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.3.5 India SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.3.6 Australia SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.4 Europe SARS-CoV-2 IgG (RBD) ELISA Forecast by Country (2023-2028)
10.4.1 Germany SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.4.2 France SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.4.3 UK SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.4.4 Italy SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.4.5 Russia SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.5 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Forecast by Region (2023-2028)
10.5.1 Egypt SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.5.2 South Africa SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.5.3 Israel SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.5.4 Turkey SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.5.5 GCC Countries SARS-CoV-2 IgG (RBD) ELISA Market Forecast
10.6 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Type (2023-2028)
10.7 Global SARS-CoV-2 IgG (RBD) ELISA Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 R&D Systems
11.1.1 R&D Systems Company Information
11.1.2 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.1.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 R&D Systems Main Business Overview
11.1.5 R&D Systems Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Ortho Clinical Diagnostics
11.3.1 Ortho Clinical Diagnostics Company Information
11.3.2 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Ortho Clinical Diagnostics Main Business Overview
11.3.5 Ortho Clinical Diagnostics Latest Developments
11.4 BD Biosciences
11.4.1 BD Biosciences Company Information
11.4.2 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.4.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BD Biosciences Main Business Overview
11.4.5 BD Biosciences Latest Developments
11.5 ZEUS Scientific
11.5.1 ZEUS Scientific Company Information
11.5.2 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.5.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 ZEUS Scientific Main Business Overview
11.5.5 ZEUS Scientific Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
11.7 ALPCO
11.7.1 ALPCO Company Information
11.7.2 ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.7.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 ALPCO Main Business Overview
11.7.5 ALPCO Latest Developments
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Company Information
11.8.2 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.8.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Enzo Life Sciences Main Business Overview
11.8.5 Enzo Life Sciences Latest Developments
11.9 BioMérieux
11.9.1 BioMérieux Company Information
11.9.2 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.9.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 BioMérieux Main Business Overview
11.9.5 BioMérieux Latest Developments
11.10 LOEWE Biochemica
11.10.1 LOEWE Biochemica Company Information
11.10.2 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.10.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 LOEWE Biochemica Main Business Overview
11.10.5 LOEWE Biochemica Latest Developments
11.11 Shenzhen YHLO Biotech
11.11.1 Shenzhen YHLO Biotech Company Information
11.11.2 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Shenzhen YHLO Biotech Main Business Overview
11.11.5 Shenzhen YHLO Biotech Latest Developments
11.12 LG
11.12.1 LG Company Information
11.12.2 LG SARS-CoV-2 IgG (RBD) ELISA Product Offered
11.12.3 LG SARS-CoV-2 IgG (RBD) ELISA Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 LG Main Business Overview
11.12.5 LG Latest Developments
12 Research Findings and Conclusion
Table 1. SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of ELISA Sets
Table 3. Major Players of ELISA Kits
Table 4. SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)
Table 7. SARS-CoV-2 IgG (RBD) ELISA Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)
Table 10. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Player (2020-2022)
Table 12. SARS-CoV-2 IgG (RBD) ELISA Key Players Head office and Products Offered
Table 13. SARS-CoV-2 IgG (RBD) ELISA Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Regions (2017-2022)
Table 18. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Country (2017-2022)
Table 20. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)
Table 22. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)
Table 24. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region (2017-2022)
Table 26. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)
Table 28. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)
Table 30. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Country (2017-2022)
Table 32. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)
Table 34. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of SARS-CoV-2 IgG (RBD) ELISA
Table 43. Key Market Challenges & Risks of SARS-CoV-2 IgG (RBD) ELISA
Table 44. Key Industry Trends of SARS-CoV-2 IgG (RBD) ELISA
Table 45. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share Forecast by Application (2023-2028)
Table 51. R&D Systems Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 52. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 53. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. R&D Systems Main Business
Table 55. R&D Systems Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 57. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Ortho Clinical Diagnostics Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 62. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 63. Ortho Clinical Diagnostics Main Business
Table 64. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Ortho Clinical Diagnostics Latest Developments
Table 66. BD Biosciences Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 67. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 68. BD Biosciences Main Business
Table 69. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. BD Biosciences Latest Developments
Table 71. ZEUS Scientific Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 72. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 73. ZEUS Scientific Main Business
Table 74. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. ZEUS Scientific Latest Developments
Table 76. Bio-Rad Laboratories Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 77. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 78. Bio-Rad Laboratories Main Business
Table 79. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Bio-Rad Laboratories Latest Developments
Table 81. ALPCO Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 82. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 83. ALPCO Main Business
Table 84. ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. ALPCO Latest Developments
Table 86. Enzo Life Sciences Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 87. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 88. Enzo Life Sciences Main Business
Table 89. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Enzo Life Sciences Latest Developments
Table 91. BioMérieux Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 92. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 93. BioMérieux Main Business
Table 94. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. BioMérieux Latest Developments
Table 96. LOEWE Biochemica Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 97. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 98. LOEWE Biochemica Main Business
Table 99. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. LOEWE Biochemica Latest Developments
Table 101. Shenzhen YHLO Biotech Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 102. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 103. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Shenzhen YHLO Biotech Main Business
Table 105. Shenzhen YHLO Biotech Latest Developments
Table 106. LG Details, Company Type, SARS-CoV-2 IgG (RBD) ELISA Area Served and Its Competitors
Table 107. LG SARS-CoV-2 IgG (RBD) ELISA Product Offered
Table 108. LG Main Business
Table 109. LG SARS-CoV-2 IgG (RBD) ELISA Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. LG Latest Developments
List of Figures
Figure 1. SARS-CoV-2 IgG (RBD) ELISA Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type in 2021
Figure 7. SARS-CoV-2 IgG (RBD) ELISA in Hospital
Figure 8. Global SARS-CoV-2 IgG (RBD) ELISA Market: Hospital (2017-2022) & ($ Millions)
Figure 9. SARS-CoV-2 IgG (RBD) ELISA in Clinic
Figure 10. Global SARS-CoV-2 IgG (RBD) ELISA Market: Clinic (2017-2022) & ($ Millions)
Figure 11. SARS-CoV-2 IgG (RBD) ELISA in Disease control and prevention system
Figure 12. Global SARS-CoV-2 IgG (RBD) ELISA Market: Disease control and prevention system (2017-2022) & ($ Millions)
Figure 13. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021
Figure 14. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Player in 2021
Figure 15. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Regions (2017-2022)
Figure 16. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)
Figure 17. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)
Figure 18. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size 2017-2022 ($ Millions)
Figure 20. Americas SARS-CoV-2 IgG (RBD) ELISA Value Market Share by Country in 2021
Figure 21. Americas SARS-CoV-2 IgG (RBD) ELISA Consumption Market Share by Type in 2021
Figure 22. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021
Figure 23. United States SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region in 2021
Figure 28. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021
Figure 29. China SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 33. India SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Country in 2021
Figure 36. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type in 2021
Figure 37. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021
Figure 38. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 39. France SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Application in 2021
Figure 46. Egypt SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country SARS-CoV-2 IgG (RBD) ELISA Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 52. APAC SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 53. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 55. United States SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 56. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 57. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 58. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 59. China SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 60. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 61. Korea SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 63. India SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 64. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 65. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 66. France SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 67. UK SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 68. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 69. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 70. Spain SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 71. Egypt SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 72. South Africa SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 73. Israel SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 74. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries SARS-CoV-2 IgG (RBD) ELISA Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...